Running Royalty Rate. COMPANY shall pay to JHU/APL a royalty of .25% on Net Sales generated by the individual components that include JHU/APL Subject IP or jointly made Subject IP. The system is currently divided into three components, the implant, the video processing unit and the glasses.
Appears in 2 contracts
Sources: Joint Research and Development Agreement (Second Sight Medical Products Inc), Joint Research and Development Agreement (Second Sight Medical Products Inc)